A Phase III, dose ranging, multi-centre, randomised, double blind, placebo controlled, home use, parallel group clinical trial of topically-applied glyceryl trinitrate (GTN) for the treatment of erectile dysfunction (ED) with an open label extension
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2019
At a glance
- Drugs Nitroglycerin (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Sponsors Futura Medical
- 08 Jan 2019 According to a Futura Medical media release, the company expects to complete this trial by the end of 2019
- 31 Oct 2018 Status changed from planning to recruiting, according to a Futura Medical media release.
- 31 Oct 2018 According to a Futura Medical media release, first patient has been enrolled in this study. The headline data of the study is expected by the end of 2019.